2A Pharma ApS: Financial statements 2024
CVR: 39391597
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 591,317 and a net result of DKK 4,297 compared with DKK -42,621 the year before. That is an increase of 271.3% compared with the year before. Equity in the 2024 report amounted to DKK 976,165. The solvency ratio was 56.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 591,317
- Profit/Loss
- DKK 4,297
- Equity
- DKK 976,165
- Total Assets
- DKK 1,731,471
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 591 t. | 4 t. | 976 t. | 2 |
| 2023 | - | 159 t. | -43 t. | 672 t. | 2 |
| 2022 | - | -210 t. | -1.5 mio. | -586 t. | 2 |
| 2021 | - | 1.9 mio. | 272 t. | 938 t. | 2 |
| 2020 | - | 2.1 mio. | 322 t. | 667 t. | 3 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
2A Pharma ApS has published its annual report for 2023. Gross profit came to DKK 159,246, and the net result was DKK -42,621.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.